Siemens Healthineers and IBM Enter into Alliance for Population Health Management

Siemens Healthineers (Erlangen, Germany) and IBM Watson Health (Armonk, New York, USA) have entered into a five-year, global strategic alliance in Population Health Management (PHM). The alliance will assist hospitals, health systems, integrated delivery networks, and other providers in delivering value-based care to patients with complex, chronic and costly conditions, like heart disease and cancer.

Both the companies plan to assist healthcare professionals in navigating unprecedented changes driven by a growing volume and diversity of health data, an aging global population, increasing prevalence of chronic diseases, changes in healthcare payment models, and the digitization and consumerization of healthcare.

Siemens Healthineers will offer PHM solutions and services from IBM Watson Health that are designed to help meet hospital and healthcare systems' demands for value-based care analytics and reporting, and patient engagement. The company will also provide consulting services to support providers in their transition to value-based care.

"Combining our strengths, Siemens Healthineers and IBM can effectively help providers transition to a value-based healthcare environment," said Matthias Platsch, head of Services at Siemens Healthineers. "We will bring the power of Siemens Healthineers' extensive relationships with providers and our deep domain expertise in clinical workflows, services, and digital health technologies to bear to help bring population health management offerings to healthcare providers. The new alliance fits perfectly into the services business of Siemens Healthineers. Thus we will enter the rapidly growing PHM market which is expected to play a significant role in end-to-end value-based healthcare."

Both the companies plan to work together to jointly develop and deploy new PHM offerings leveraging each company's expertise and assets, including those added to the Watson Health portfolio from acquisitions such as Phytel and Explorys.

"We are at an unprecedented time in healthcare. Mature and developing markets are increasingly focused on how patient outcomes are optimized, quality is standardized among individuals and across populations, and costs are reduced," said Deborah DiSanzo, general manager for IBM Watson Health. "Siemens and IBM are ideal partners to work at the forefront of this evolution and enable personalized healthcare in the US and globally."

Related Links:
Siemens Healthineers
IBM Watson Health